Furthermore, we elevated miR‐500a‐3p expression in HCC cells and found that upregulating miR‐500a‐3p significantly reduced SOCS2 expression in exosomes‐activated LX2 cells (Figure 4K). The gene discussed is SOCS2; the disease is hepatocellular carcinoma.